Several analysts have recently updated their ratings and price targets for RedHill Biopharma Ltd – (NASDAQ: RDHL): 9/29/2015 – RedHill Biopharma Ltd – was upgraded by analysts at Zacks from a “sell” rating to a “hold” rating. According to Zacks, “RedHill Biopharma Ltd. is an emerging Israeli biopharmaceutical company focused on the development and acquisition […]
